Drug Type Small molecule drug |
Synonyms YK 2168, YK-2168, YK2168 |
Target |
Mechanism CDK9 inhibitors(Cyclin-dependent kinase 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 19 Jan 2022 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 19 Jan 2022 | |
Non-Hodgkin Lymphoma | Phase 1 | CN | 19 Jan 2022 | |
Non-Hodgkin Lymphoma | Phase 1 | CN | 19 Jan 2022 |